Charles Schwab Investment Management »

Intellia Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $20M 728k 27.51
2023-12-31 $21M 700k 30.49
2023-09-30 $22M 681k 31.62
2023-06-30 $39M 953k 40.78
2023-03-31 $32M 869k 37.27
2022-12-31 $31M 893k 34.89
2022-09-30 $43M 772k 55.96
2022-06-30 $37M 713k 51.76
2022-03-31 $51M 696k 72.67
2021-12-31 $81M 682k 118.24
2021-09-30 $90M 667k 134.15
2021-06-30 $74M 457k 161.91
2021-03-31 $35M 431k 80.26
2020-12-31 $20M 370k 54.40
2020-09-30 $6.8M 342k 19.88
2020-06-30 $6.3M 301k 21.02
2020-03-31 $3.0M 247k 12.23
2019-12-31 $3.6M 244k 14.67
2019-09-30 $3.2M 239k 13.35
2019-06-30 $3.2M 196k 16.37
2019-03-31 $3.1M 183k 17.08
2018-12-31 $2.3M 172k 13.65
2018-09-30 $5.0M 174k 28.63
2018-06-30 $3.6M 130k 27.36
2018-03-31 $1.9M 91k 21.10
2017-12-31 $1.5M 79k 19.22
2017-09-30 $1.4M 58k 24.86
2017-06-30 $683k 43k 16.01
2017-03-31 $380k 27k 14.12
2016-12-31 $333k 25k 13.13
2016-09-30 $409k 24k 17.06
2016-06-30 $486k 23k 21.36